Citation 86037

MIN,BS: TOMIYAMA,M: MA,CM: NAKAMURA,N: HATTORI,M:. (2001). KAEMPFEROL ACETYLRHAMNOSIDES FROM THE RHIZOME OF DRYOPTERIS CRASSIRHIZOMA AND THEIR INHIBITORY EFFECTS ON THREE DIFFERENT ACTIVITIES OF HUMAN IMMUNODEFICIENCY VIRUS-1 REVERSE TRANSCRIPTASE.. 49(5)

Citation Details

Title	KAEMPFEROL ACETYLRHAMNOSIDES FROM THE RHIZOME OF DRYOPTERIS CRASSIRHIZOMA AND THEIR INHIBITORY EFFECTS ON THREE DIFFERENT ACTIVITIES OF HUMAN IMMUNODEFICIENCY VIRUS-1 REVERSE TRANSCRIPTASE.
Authors	MIN,BS: TOMIYAMA,M: MA,CM: NAKAMURA,N: HATTORI,M:
Year	2001
Volume	49
Issue	5

Summary

Year: 2001

Journal: Unknown

Organisms and Their Experiments (2)

Unknown organism

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	Not specified	PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTED	KAEMPFEROL	None
2	RNA DEPENDENT DNA POLYMERASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	KAEMPFEROL	WEAK ACTIVITY
3	RIBONUCLEASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	KAEMPFEROL	INACTIVE
4	DNA DEPENDENT RNA POLYMERASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	KAEMPFEROL	ACTIVE

Dryopteris crassirhizoma (DRYOPTERIDACEAE)

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	Not specified	VOUCHER SPECIMEN REPORTED FORUV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	CRASSIRHIZOMOSIDE A	None
2	RIBONUCLEASE INHIBITION	PHARMACOLOGY OF EXTRACT - IN VITRO	None	ACTIVE
3	REVERSE TRANSCRIPTASE INHIBITION	PHARMACOLOGY OF EXTRACT - IN VITRO	None	ACTIVE
4	RNA DEPENDENT DNA POLYMERASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CRASSIRHIZOMOSIDE A	WEAK ACTIVITY
5	RIBONUCLEASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CRASSIRHIZOMOSIDE A	INACTIVE
6	DNA DEPENDENT RNA POLYMERASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CRASSIRHIZOMOSIDE A	ACTIVE
7	Not specified	UV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	CRASSIRHIZOMOSIDE B	None
8	Not specified	UV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	CRASSIRHIZOMOSIDE C	None
9	RNA DEPENDENT DNA POLYMERASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CRASSIRHIZOMOSIDE C	INACTIVE
10	RIBONUCLEASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CRASSIRHIZOMOSIDE C	INACTIVE
11	DNA DEPENDENT RNA POLYMERASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CRASSIRHIZOMOSIDE C	INACTIVE
12	Not specified	UV SPECTRUM GIVEN FORISOLATION AND IDENTIFICATION OFMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATA	SUTCHUENOSIDE A	None
13	RNA DEPENDENT DNA POLYMERASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	SUTCHUENOSIDE A	WEAK ACTIVITY
14	RIBONUCLEASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	SUTCHUENOSIDE A	INACTIVE
15	DNA DEPENDENT RNA POLYMERASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	SUTCHUENOSIDE A	ACTIVE